Kedudukan dalam Saham
#28270
Syntara Limited is a clinical-stage biopharmaceutical company dedicated to... Syntara Limited is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies by targeting extracellular matrix dysfunction, primarily through amine oxidase chemistry. Headquartered in Frenchs Forest, Australia, the company's research pipeline focuses on blood cancers as well as a range of inflammatory and fibrotic disorders. Its leading investigational compound, amsulostat, is currently in Phase 1c/2 clinical trials for the treatment of myelofibrosis, a bone marrow cancer, and is also being evaluated for myelodysplastic syndrome. Beyond this, Syntara is advancing several other promising drug candidates. These include a suite of topical pan-LOX inhibitors: SNT-9465, which is undergoing Phase 1a/b study for hypertrophic scars, and SNT-6302, designed for keloid scars. Furthermore, SNT-4728 is in development to manage sleep disorders and to potentially slow the progression of neurodegenerative conditions by mitigating neuroinflammation. The company's broader therapeutic ambitions extend to various fibrotic and inflammatory diseases such as kidney fibrosis, MASH (metabolic dysfunction-associated steatohepatitis), pulmonary fibrosis, and cardiac fibrosis. Incorporated in 1998, the company was formerly known as Pharmaxis Ltd before adopting the name Syntara Limited in December 2023.
Harga Saham
$0.0183374
Disegerakkan terakhir: 2026-08-19
Perubahan (1 hari)
-3.70%
Perubahan (1 tahun)
9.62%
Perdagangan Syntara Limited (SNT)
Harga SNT dengan permodalan pasaran b
Modal pasaran bagi Syntara Limited(SNT)
Modal Pasaran: $27.51M
Sehingga August 2026, Syntara Limited mempunyai modal pasaran sebanyak $27.51M. Ini menjadikan Syntara Limited syarikat ke-28270th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran Syntara Limited dari 2003 hingga 2026
SNT berbanding dengan 5 teratas yang paling popular stocks
| Harga SNT |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.301T
|
+19,267,682.92%
|
|
|
|
|
$4.634T
|
+16,843,248.04%
|
|
|
|
|
$4.143T
|
+15,058,953.48%
|
|
|
|
|
$3.589T
|
+13,046,679.38%
|
|
|
|
|
$2.857T
|
+10,384,438.20%
|
